Cindy Orser

Cindy Orser has an extensive work experience in the science and healthcare industries. Cindy began their career in 1999 as the Director of Biodefense at Areté Associates, where they initiated, funded and managed a biosensor R&D effort focused on detecting relevant low signals among high background. In 2003, they moved to Adlyfe Inc. as the Director of R&D. From 2007 to 2020, they held various positions including COO at ASDx Biosystems Inc., President at Big Sky Biosystems Inc., Chief Science Officer at Fantoosh, and Chief Science Officer and Board Member at Digipath Inc., where they created a replicable cannabis testing environment with validated standard operating procedures. In 2020, they were appointed Chief Science Advisor at TAAT Global (CSE:TAAT OTC:TOBAF) and Science Advisor at CLIP Laboratories. Currently, they are the Chief Science Officer at Apothercare, a Women's Health Care Advocacy and research company.

Cindy Orser obtained their Ph.D. in Genetics and Plant Pathology from the University of California, Berkeley between 1980 and 1985. Prior to that, they earned their B.S. in Botany and Philosophy from Montana State University-Bozeman between 1974 and 1978.